Title: 2025-2026 Regular Session HR 316 PN 2311 Bill Text (HTM)
Official Title: 
Number of Sections: 1
Source: versions - Printer's No. PN2311
Media Type: text/html

================================================================================

Section 1:
2025-2026 Regular Session HR 316 PN 2311 Bill Text (HTM) See other bills under thesame topic PRINTER'S NO. 2311 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.316 Session of 2025 INTRODUCED BY MOUL, COOK, FREEMAN, VENKAT, RIVERA, WAXMAN, NEILSON, HEFFLEY, CAUSER, FEE, ROWE, FLICK AND GALLAGHER, SEPTEMBER 11, 2025 REFERRED TO COMMITTEE ON HEALTH, SEPTEMBER 15, 2025 A RESOLUTIONRecognizing the week of September 21 through 28, 2025, as "Frontotemporal Degeneration Awareness Week" in Pennsylvania.WHEREAS, Frontotemporal Degeneration (FTD) is identified in the National Plan to Address Alzheimer's Disease as a related dementia and included as a priority in the goals and strategies to achieve the vision of a nation free of Alzheimer's disease and related dementias; andWHEREAS, FTD is referenced in the Pennsylvania State Plan for Alzheimer's Disease and Related Disorders, which contains recommendations to define a response to the current and anticipated growth of the number of Pennsylvanians living with Alzheimer's Disease and related disorders; andWHEREAS, The Association for Frontotemporal Degeneration reports that FTD is a terminal and incurable neurodegenerative disease affecting the frontal and temporal lobes, causing impairments to speech, personality, behavior and motor skills which constitutes a major public health concern; and1234567891011121314151617 WHEREAS, It takes an average of 3.6 years from start of symptoms to get an accurate diagnosis of FTD with average life expectancy of 7 to 13 years after start of symptoms; andWHEREAS, FTD strikes people as young as 17 years of age and as old as 87 years of age with the largest percentage of those affected being in their 40s to 60s, rendering people in the prime of life unable to work or function normally; andWHEREAS, FTD represents an estimated 5% to 15% of all dementia cases and is the most common form of dementia for people under 60 years of age; andWHEREAS, FTD is often misdiagnosed as a psychiatric problem or other neurodegenerative disease because of the wide range of cognitive and behavioral symptoms and their young onset; andWHEREAS, FTD imposes average annual costs associated with care and living with the disease that are approximately double those of Alzheimer's disease; andWHEREAS, FTD often affects a person's ability to express emotions and to show affection and empathy for loved ones; andWHEREAS, In the behavioral variant of FTD, a person's sense of social graces and appropriate behavior can be lost, and their personality may be significantly changed; andWHEREAS, In the language variants of FTD, primary progressive aphasia, a person may have trouble producing speech and understanding grammar, lose the meaning of words or become hesitant in their speech, and may eventually become mute; andWHEREAS, In the movement variants of FTD, a person may experience muscle weakness, falling, loss of balance, difficulty making speech and difficulty swallowing or choking; andWHEREAS, While there has never been a global epidemiology study of FTD, it is estimated that more than 60,000 people are 20250HR0316PN2311 - 2 - 123456789101112131415161718192021222324252627282930 affected in the United States today; andWHEREAS, The Association for Frontotemporal Degeneration is the leading national organization exclusively focused on the spectrum of FTD disorders with a mission to improve the quality of life of people affected by FTD and drive research to a cure; andWHEREAS, It is imperative that there be greater awareness of this serious disease and more must be done to increase activity at the national, State and local levels; therefore be itRESOLVED, That the House of Representatives recognize the week of September 21 through 28, 2025, as "Frontotemporal Degeneration Awareness Week" in Pennsylvania.20250HR0316PN2311 - 3 - 123456789101112


================================================================================

Raw Text:
2025-2026 Regular Session HR 316 PN 2311 Bill Text (HTM) See other bills under thesame topic PRINTER'S NO. 2311 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.316 Session of 2025 INTRODUCED BY MOUL, COOK, FREEMAN, VENKAT, RIVERA, WAXMAN, NEILSON, HEFFLEY, CAUSER, FEE, ROWE, FLICK AND GALLAGHER, SEPTEMBER 11, 2025 REFERRED TO COMMITTEE ON HEALTH, SEPTEMBER 15, 2025 A RESOLUTIONRecognizing the week of September 21 through 28, 2025, as "Frontotemporal Degeneration Awareness Week" in Pennsylvania.WHEREAS, Frontotemporal Degeneration (FTD) is identified in the National Plan to Address Alzheimer's Disease as a related dementia and included as a priority in the goals and strategies to achieve the vision of a nation free of Alzheimer's disease and related dementias; andWHEREAS, FTD is referenced in the Pennsylvania State Plan for Alzheimer's Disease and Related Disorders, which contains recommendations to define a response to the current and anticipated growth of the number of Pennsylvanians living with Alzheimer's Disease and related disorders; andWHEREAS, The Association for Frontotemporal Degeneration reports that FTD is a terminal and incurable neurodegenerative disease affecting the frontal and temporal lobes, causing impairments to speech, personality, behavior and motor skills which constitutes a major public health concern; and1234567891011121314151617 WHEREAS, It takes an average of 3.6 years from start of symptoms to get an accurate diagnosis of FTD with average life expectancy of 7 to 13 years after start of symptoms; andWHEREAS, FTD strikes people as young as 17 years of age and as old as 87 years of age with the largest percentage of those affected being in their 40s to 60s, rendering people in the prime of life unable to work or function normally; andWHEREAS, FTD represents an estimated 5% to 15% of all dementia cases and is the most common form of dementia for people under 60 years of age; andWHEREAS, FTD is often misdiagnosed as a psychiatric problem or other neurodegenerative disease because of the wide range of cognitive and behavioral symptoms and their young onset; andWHEREAS, FTD imposes average annual costs associated with care and living with the disease that are approximately double those of Alzheimer's disease; andWHEREAS, FTD often affects a person's ability to express emotions and to show affection and empathy for loved ones; andWHEREAS, In the behavioral variant of FTD, a person's sense of social graces and appropriate behavior can be lost, and their personality may be significantly changed; andWHEREAS, In the language variants of FTD, primary progressive aphasia, a person may have trouble producing speech and understanding grammar, lose the meaning of words or become hesitant in their speech, and may eventually become mute; andWHEREAS, In the movement variants of FTD, a person may experience muscle weakness, falling, loss of balance, difficulty making speech and difficulty swallowing or choking; andWHEREAS, While there has never been a global epidemiology study of FTD, it is estimated that more than 60,000 people are 20250HR0316PN2311 - 2 - 123456789101112131415161718192021222324252627282930 affected in the United States today; andWHEREAS, The Association for Frontotemporal Degeneration is the leading national organization exclusively focused on the spectrum of FTD disorders with a mission to improve the quality of life of people affected by FTD and drive research to a cure; andWHEREAS, It is imperative that there be greater awareness of this serious disease and more must be done to increase activity at the national, State and local levels; therefore be itRESOLVED, That the House of Representatives recognize the week of September 21 through 28, 2025, as "Frontotemporal Degeneration Awareness Week" in Pennsylvania.20250HR0316PN2311 - 3 - 123456789101112